- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Telmisartan & Hydrochlorothiazide
Total 656 results
-
Hospital Israelita Albert EinsteinLibbs Farmacêutica LTDARecruiting
-
Vanderbilt UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Second Affiliated Hospital, School of Medicine,...National Clinical Research Center, Southern Medical University; Ningbo Yinzhou...Completed
-
William Beaumont HospitalsNovartis PharmaceuticalsWithdrawnHypertension | Diabetes Type 2United States
-
GlaxoSmithKlineTerminatedInfections, Urinary TractFrance, United States, Russian Federation, Spain, Greece, Canada
-
NovartisCompleted
-
University of OuluCompleted
-
Biomedis International Ltd.UnknownStroke | Hypertension | Blood PressureJapan
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | HypertensionUnited States
-
Bristol-Myers SquibbSanofiCompletedHypertension | Metabolic SyndromeSpain, Italy, Russian Federation, Norway, France, Germany
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Colombia, Spain, Germany, Taiwan, Russian Federation, Argentina, France, Italy, Korea, Republic of, Japan, Greece
-
University of FloridaAbbottCompletedCoronary Artery Disease | HypertensionUnited States
-
ImmunoGen, Inc.TerminatedSmall Cell Lung CancerUnited States, Spain, Canada, United Kingdom
-
Boehringer IngelheimCompleted
-
Ospedale San RaffaeleUnknown
-
University Hospital, Strasbourg, FranceTerminated
-
Novartis PharmaceuticalsCompleted
-
Umeå UniversityAstraZeneca; Sahlgrenska University Hospital, SwedenCompletedHypertension | ObesitySweden
-
NovartisCompletedHypertension, Dyslypidaemia
-
James J. Peters Veterans Affairs Medical CenterCompletedOrthostatic Hypotension | Spinal Cord InjuryUnited States
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
ANRS, Emerging Infectious DiseasesUniversity of Bordeaux; PACCI ProgramUnknownCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID-19 Drug TreatmentCôte D'Ivoire
-
Third Military Medical UniversityCompletedHypertension | Obesity | DiabetesChina
-
Brigham and Women's HospitalNational Institutes of Health (NIH)CompletedDiabetes Mellitus | Albuminuria | Endothelial DysfunctionUnited States
-
Boehringer IngelheimCompleted
-
University of California, San DiegoCompletedObstructive Sleep Apnea
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Hospital General de MexicoCompleted
-
GlaxoSmithKlineWithdrawn
-
NovartisCompletedEssential HypertensionSpain, United States, Belgium, Egypt, Germany, Poland, Slovakia, Turkey
-
Guangdong Provincial People's HospitalCompleted
-
NovartisCompletedHypertensionUnited States, Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland
-
Boehringer IngelheimCompleted
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
AstraZenecaCompletedHypertensionUnited Kingdom, Germany, Sweden, Estonia, Lithuania, Poland, Ukraine, Denmark, Netherlands, France, Former Serbia and Montenegro
-
NovartisCompletedEssential Hypertension ( Mild to Moderate)Romania, Slovakia, Hungary, France
-
Anna Posadzy-MałaczyńskaCompleted
-
University of Texas Southwestern Medical CenterNovartis PharmaceuticalsWithdrawn
-
AstraZenecaCompletedStage II HypertensionKorea, Republic of
-
Immunobiology Research InstituteCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompletedHypertensionKorea, Republic of
-
Boehringer IngelheimCompleted
-
Iain BressendorffRecruitingDiabetic Kidney DiseaseDenmark
-
KU LeuvenUniversity of Yaounde; University of Kinshasa; Yaounde Central Hospital; University... and other collaboratorsCompletedBlood PressureCameroon, Côte D'Ivoire, Gabon, Nigeria, Senegal
-
University of California, San DiegoCompleted
-
AstraZenecaCompletedHypertensionRussian Federation, Latvia, Romania, Slovakia, Belgium, Malta